Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
This entry reports the completion of a longitudinal clinical trial evaluating the effects of Copaxone (glatiramer acetate) in relapsing-remi…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Rehabilitation Study in MS Patients [Phase 4]
A Phase 4 rehabilitation study in relapsing-remitting multiple sclerosis sponsored by Bayer was terminated. Results from the terminated tria…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Study Evaluating CCI-779 in Relapsing Multiple Sclerosis [Phase 2]
Phase 2 study evaluating CCI-779 (temsirolimus) in relapsing multiple sclerosis has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Treatment Interruption of Natalizumab [Phase 2]
A Phase 2 trial evaluating interruption of natalizumab therapy in relapsing-remitting multiple sclerosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients [Phase 2]
Phase 2 dose-finding study of ofatumumab in relapsing-remitting multiple sclerosis completed; results were posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2012-12-03Clinical Trial Update: Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis [NA]
Clinical trial update about a study evaluating two therapeutic strategies for aggressive relapsing-remitting multiple sclerosis; no phase or…
-
CLINICAL_TRIALS research · 2012-11-15Clinical Trial Update: BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program
This completed observational trial evaluates adherence to Betaferon (interferon beta-1b) in patients with relapsing-remitting or secondary-p…
-
CLINICAL_TRIALS research · 2012-11-01Clinical Trial Update: Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors
An observational Portuguese study evaluating adherence in multiple sclerosis patients after conversion to Betaferon (interferon beta-1b) via…
-
CLINICAL_TRIALS research · 2012-10-12Clinical Trial Update: Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial update examining how vitamin A affects RAR gene expression in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] [Phase 2]
A Phase 2 study tested adding minocycline to Interferon beta-1a (Rebif) in relapsing-remitting multiple sclerosis; the trial was terminated …
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient [Phase 4]
Update on a Phase 4 clinical trial evaluating the effects of Vitamin A on gene expression in patients with relapsing-remitting multiple scle…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]
This report presents long-term efficacy and safety data for fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis from…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine [Phase 2]
A Phase 2 safety and efficacy study evaluates Copaxone (glatiramer acetate) administered with N-acetylcysteine for Relapsing-Remitting Multi…
-
CLINICAL_TRIALS withdrawal · 2012-04-16Clinical Trial Update: QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea
The clinical trial evaluating BETaferon for quality of life in early relapsing-remitting multiple sclerosis in Korea has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients [Phase 4]
Phase 4 clinical trial evaluating emotional disorders in relapsing-remitting multiple sclerosis patients treated with interferon beta; resul…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Sensori-motor Integration Training in Multiple Sclerosis [EARLY_Phase 1]
This update notes the completion of an early-phase 1 trial evaluating sensori-motor integration training for relapsing-remitting multiple sc…
-
FDA approval · 2012-03-01FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation, updating the pro…
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
A completed clinical trial update detailing pharmacokinetic, immunological, and biochemical sample collection and analysis in a natalizumab-…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b [Phase 2]
Phase 2 trial evaluating the efficacy, safety and tolerability of atorvastatin 40 mg in patients with relapsing-remitting multiple sclerosis…
-
CLINICAL_TRIALS research · 2011-08-16Clinical Trial Update: Impact of Vitamin A on Multiple Sclerosis (MS) [Phase 4]
This clinical trial update from Tehran University of Medical Sciences investigates whether Vitamin A affects relapsing-remitting multiple sc…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
A completed trial evaluating the safety and effectiveness of adding monthly dexamethasone to weekly Avonex in people with relapsing-remittin…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone [Phase 4]
Phase IV study evaluating Rebif (interferon beta-1a) 44 mcg given subcutaneously three times weekly versus no treatment after mitoxantrone i…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Safety of New Formulation of Glatiramer Acetate [Phase 3]
A Phase 3 trial assessing the safety of a new formulation of glatiramer acetate in relapsing-remitting multiple sclerosis has completed with…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis. [Phase 2]
A Phase 2 study evaluated the safety and effectiveness of Novantrone therapy followed by Copaxone in Relapsing-Remitting Multiple Sclerosis.…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline [Phase 2]
Phase 2 safety and efficacy study evaluating Copaxone in combination with minocycline for relapsing-remitting multiple sclerosis; the trial …